A detailed history of State Street Corp transactions in Care Dx, Inc. stock. As of the latest transaction made, State Street Corp holds 2,036,089 shares of CDNA stock, worth $42.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,036,089
Previous 2,107,830 3.4%
Holding current value
$42.6 Million
Previous $32.7 Million 94.19%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$14.41 - $33.99 $1.03 Million - $2.44 Million
-71,741 Reduced 3.4%
2,036,089 $63.6 Million
Q2 2024

Aug 14, 2024

SELL
$7.56 - $16.15 $15.8 Million - $33.7 Million
-2,088,510 Reduced 49.77%
2,107,830 $32.7 Million
Q1 2024

May 15, 2024

BUY
$7.96 - $12.37 $11.1 Million - $17.3 Million
1,400,073 Added 50.07%
4,196,340 $44.4 Million
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $4.47 Million - $11.7 Million
-912,881 Reduced 24.61%
2,796,267 $33.6 Million
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $3.32 Million - $5.35 Million
-474,880 Reduced 11.35%
3,709,148 $26 Million
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $5.28 Million - $6.57 Million
-694,008 Reduced 14.23%
4,184,028 $35.6 Million
Q1 2023

May 15, 2023

SELL
$8.83 - $17.61 $7.68 Million - $15.3 Million
-869,208 Reduced 15.12%
4,878,036 $44.6 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $16.3 Million - $30.1 Million
1,501,219 Added 35.36%
5,747,244 $65.6 Million
Q3 2022

Nov 15, 2022

BUY
$16.06 - $26.39 $503,400 - $827,194
31,345 Added 0.74%
4,246,025 $72.3 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $24.1 Million - $46.6 Million
1,174,094 Added 38.61%
4,214,680 $90.5 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $21 Million - $34.8 Million
745,779 Added 32.5%
3,040,586 $112 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $21 Million - $37.5 Million
509,420 Added 28.53%
2,294,807 $104 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $17.8 Million - $27.6 Million
300,364 Added 20.23%
1,785,387 $113 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $11.3 Million - $17 Million
-179,183 Reduced 10.77%
1,485,023 $136 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $10.8 Million - $17.9 Million
-187,649 Reduced 10.13%
1,664,206 $113 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $11.1 Million - $20.6 Million
-267,586 Reduced 12.63%
1,851,855 $134 Million
Q3 2020

Nov 10, 2020

SELL
$30.88 - $37.94 $835,427 - $1.03 Million
-27,054 Reduced 1.26%
2,119,441 $80.4 Million
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $8.08 Million - $15.1 Million
-426,271 Reduced 16.57%
2,146,495 $76.1 Million
Q1 2020

May 11, 2020

BUY
$13.94 - $28.25 $35.9 Million - $72.7 Million
2,572,766 New
2,572,766 $56.2 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.12B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.